CTC Alternative Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
CTC Alternative Strategies's VRTX Position: Q2 2026 in Review
CTC Alternative Strategies opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 1,760 shares worth $874K. The stake represents 1.26% of the portfolio and ranks #20 among its holdings. This is a return to the name: CTC Alternative Strategies previously reported a position in VRTX as recently as Q2 2024.
CTC Alternative Strategies first reported a position in VRTX in Q2 2024 and has held it in 2 quarters since. The position peaked at $1.17M in Q2 2024. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- CTC Alternative Strategies held 1,760 shares of Vertex Pharmaceuticals worth $874K as of Q2 2026.
- Vertex Pharmaceuticals was a new CTC Alternative Strategies position in Q2 2026.
- Vertex Pharmaceuticals made up 1.26% of CTC Alternative Strategies's portfolio in Q2 2026, its #20 holding.
- CTC Alternative Strategies first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
- CTC Alternative Strategies's Vertex Pharmaceuticals position peaked at $1.17M in Q2 2024.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on CTC Alternative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.